Clinical Trials Directory

Trials / Completed

CompletedNCT05864209

Phthalate and Bisphenol Exposure During Minipuberty

An Intervention to Reduce Phthalate and Bisphenol Exposure During the Critical Period of Minipuberty

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Phthalates and bisphenols have been detected in a range of infant care products. This pilot study will test whether intervening on these sources of exposure during the critical period of minipuberty affects infants' body burden of phthalates and bisphenols. Investigators will recruit 10 participants from the ongoing NYU Children's Health and Development Study (CHES) cohort study who are \>=37 weeks gestation, carrying a male fetus, and intending to breastfeed. Investigators will randomly assign them to use either conventional baby products or phthalate- and bisphenol-free baby products for the first three months of their children's lives. Toward the end of the intervention, investigators will collect maternal breast milk and infant urine, and assay samples for phthalate metabolite and bisphenol concentrations.

Conditions

Interventions

TypeNameDescription
OTHERPhthalate- and Bisphenol-free Baby Products3-month supply. Products include wipes and diaper cream.
OTHERCloth DiapersSubscription to cloth diaper service.
OTHERConventional Disposable Diapers3-month supply.
OTHERConventional Baby ProductsProducts include wipes and diaper cream.

Timeline

Start date
2023-05-16
Primary completion
2024-01-11
Completion
2024-01-11
First posted
2023-05-18
Last updated
2025-06-10
Results posted
2025-05-21

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05864209. Inclusion in this directory is not an endorsement.